# GBA Pharma GmbH - Inspection Records

Source: https://www.keypedia.com/companies/gba-pharma-gmbh/9493ddfc-e675-4367-ac97-c959ddafdf46

> Inspection records and compliance data for GBA Pharma GmbH in Neuried, None. Access full analysis and detailed observations.

---

## Details

- Name: GBA Pharma GmbH
- FEI Number: 3004477049
- City: Neuried
- State: None
- Country Name: Germany
- Address Line 1: Anna-Sigmund-Strasse 7
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1261571 - GBA Pharma GmbH - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/751a5f9b-9de0-4e58-bf04-1e83e7aaae9c) — source: FDA, date: December 11, 2024
- [FDA Inspection 1261571 - GBA Pharma GmbH - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/5aead7de-0b54-4145-a0a2-1ff609282fa9) — source: FDA, date: December 11, 2024
- [FDA Inspection 1261571 - GBA Pharma GmbH - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/318881b7-6823-4eac-8628-d1a963a63405) — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2024
- [FDA Inspection 1261571 - GBA Pharma GmbH - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/79c5e286-5b6d-4d07-851e-1a3082e837ea) — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2024
- [FDA Inspection 1070434 - GBA Pharma GmbH - 2018-10-12](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/30ffd245-ccb0-457d-95fe-52465980c28e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 12, 2018
- [FDA Inspection 865034 - GBA Pharma GmbH - 2013-10-18](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/0d2c79c2-414b-480f-85b4-702e7dd15250) — classification: No Action Indicated (NAI), source: FDA, date: October 18, 2013
- [FDA Inspection 607366 - GBA Pharma GmbH - 2009-07-14](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/d49a2b54-5008-47bb-b206-50348b28dbdb) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2009

## Related Companies

- [Fougera Pharmaceuticals  Inc.](https://www.keypedia.com/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b)
- [Particle Technology Group, LLC](https://www.keypedia.com/companies/particle-technology-group-llc/739b37e7-35ae-45aa-a515-a9d4d01fccb7)
- [Element Materials Technology Pharma USA LLC](https://www.keypedia.com/companies/element-materials-technology-pharma-usa-llc/d40408f6-37dd-44fb-8760-20aa927a8e8c)
- [QualTech Laboratories, Inc.](https://www.keypedia.com/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/9e5e908d-150e-4cb7-9d39-ab0eef6c4c0e)
- [Eurofins Biolab S.r.l.](https://www.keypedia.com/companies/eurofins-biolab-srl/3f1b31b8-2af2-4083-8cdb-3e0fbf994b22)
- [Eurofins BioPharma Product Testing Columbia, LLC](https://www.keypedia.com/companies/eurofins-biopharma-product-testing-columbia-llc/b616a9a6-094c-4f02-80ba-59880916eaf2)
- [R.D. Laboratories Inc.](https://www.keypedia.com/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [LabCorp Early Development Laboratories Limited.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad)
- [Eurofins Ams Laboratories Pty Limited](https://www.keypedia.com/companies/eurofins-ams-laboratories-pty-limited/74537d96-5f56-4d70-894c-6869cae9677d)